Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 775310
                    [Title] => Int'l webcast on enhancing blood pressure control held
                    [Summary] => 
At least two-thirds of patients do not achieve guideline-recommended blood pressure (BP) targets, often due to poor treatment adherence. Moreover, most patients with hypertension require two or more blood pressure-lowering drugs to achieve BP goals.
                    [DatePublished] => 2012-02-09 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 659934
                    [Title] => Pill combines 3 blood pressure medications
                    [Summary] => 
Novartis Healthcare Philippines has launched the only high blood pressure treatment that combines three medications in a single pill.
                    [DatePublished] => 2011-02-24 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 253068
                    [Title] => Rexin-G: Breakthrough in cancer therapy
                    [Summary] => Michael Miller, an American businessman from North Carolina, was diagnosed with 
pancreatic cancer in May 2003. He underwent standard chemotherapy that started in June and continued until January this year. "About October or November last year, I read about Rexin-G and Dr. Erlinda Gordon who developed this product," Miller relates. "Through other family members who were involved with the University of Southern California where Dr. Gordon was  a faculty member, we were able to make some connections." 

                    [DatePublished] => 2004-06-08 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1432730
                    [AuthorName] => Julie Cabatit-Alegre
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

DR. GORDON

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 775310
                    [Title] => Int'l webcast on enhancing blood pressure control held
                    [Summary] => 
At least two-thirds of patients do not achieve guideline-recommended blood pressure (BP) targets, often due to poor treatment adherence. Moreover, most patients with hypertension require two or more blood pressure-lowering drugs to achieve BP goals.
                    [DatePublished] => 2012-02-09 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 659934
                    [Title] => Pill combines 3 blood pressure medications
                    [Summary] => 
Novartis Healthcare Philippines has launched the only high blood pressure treatment that combines three medications in a single pill.
                    [DatePublished] => 2011-02-24 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 253068
                    [Title] => Rexin-G: Breakthrough in cancer therapy
                    [Summary] => Michael Miller, an American businessman from North Carolina, was diagnosed with 
pancreatic cancer in May 2003. He underwent standard chemotherapy that started in June and continued until January this year. "About October or November last year, I read about Rexin-G and Dr. Erlinda Gordon who developed this product," Miller relates. "Through other family members who were involved with the University of Southern California where Dr. Gordon was  a faculty member, we were able to make some connections." 

                    [DatePublished] => 2004-06-08 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1432730
                    [AuthorName] => Julie Cabatit-Alegre
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

        )

)

abtest

Int'l webcast on enhancing blood pressure control held

February 9, 2012 - 12:00am

At least two-thirds of patients do not achieve guideline-recommended blood pressure (BP) targets, often due to poor treatment adherence. Moreover, most patients with hypertension require two or more blood pressure-lowering...

Science and Environment

Pill combines 3 blood pressure medications

February 24, 2011 - 12:00am

Novartis Healthcare Philippines has launched the only high blood pressure treatment that combines three medications in a single pill.

Science and Environment

Rexin-G: Breakthrough in cancer therapy

By Julie Cabatit-Alegre | June 8, 2004 - 12:00am

Michael Miller, an American businessman from North Carolina, was diagnosed with pancreatic cancer in May 2003. He underwent standard chemotherapy that started in June and continued until January this year. "About...

Health And Family